Cargando…
The SARS-CoV-2 N Protein Is a Good Component in a Vaccine
Autores principales: | Ahlén, Gustaf, Frelin, Lars, Nikouyan, Negin, Weber, Friedemann, Höglund, Urban, Larsson, Olivia, Westman, Marie, Tuvesson, Ola, Gidlund, Eva-karin, Cadossi, Matteo, Appelberg, Sofia, Mirazimi, Ali, Sällberg, Matti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459553/ https://www.ncbi.nlm.nih.gov/pubmed/32661140 http://dx.doi.org/10.1128/JVI.01279-20 |
Ejemplares similares
-
A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells
por: Appelberg, Sofia, et al.
Publicado: (2022) -
A DNA-based vaccine protects against Crimean-Congo hemorrhagic fever virus disease in a Cynomolgus macaque model
por: Hawman, David W., et al.
Publicado: (2020) -
Functional Aspects of Intrahepatic Hepatitis B Virus-specific T Cells Induced by Therapeutic DNA Vaccination
por: Brass, Anette, et al.
Publicado: (2015) -
Enhanced Seroconversion to West Nile Virus Proteins in Mice by West Nile Kunjin Replicon Virus-like Particles Expressing Glycoproteins from Crimean–Congo Hemorrhagic Fever Virus
por: Tran, Pham-Tue-Hung, et al.
Publicado: (2022) -
Functional differences in hepatitis C virus nonstructural (NS) 3/4A- and 5A-specific T cell responses
por: Holmström, Fredrik, et al.
Publicado: (2016)